Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
15/10/2025 22:45
Innocan Pharma Corp IP40.F: INNOCAN PHARMA CORP - LIPOSOMAL CBD INJECTION TECHNOLOGY PATENT ALLOWED IN JAPAN Source text: ID:nPreTnWSba Further company coverage: IP40.F
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation